Patients with a documented history of chronic pancreatitis or more than one episode of acute pancreatitis should not use GLP-1 agents outside of a setting where a gastroenterologist is involved in the treatment plan
Mudd SH, Levy HL, and Scovby F (1995)
A licensed physician determines whether combination therapy is appropriate based on your individual health profile and treatment goals
Research about the efficacy and safety of senna was submitted to the FDA, and sennacontaining products were allowed to stay in the OTC category
Conclusions Although studies have demonstrated the efficacy of GLP-1 receptor agonists (GLP-1 RAs) and SGLT-2 inhibitors in improving conditions associated with new-onset diabetes mellitus (DM) and chronic kidney disease (CKD), there is a scarcity of data regarding their use after liver transplantation
Effect of curcumin in comparison with trichostatin A on the reactivation of estrogen receptor alpha gene expression, cell growth inhibition and apoptosis induction in hepatocellular carcinoma hepa 1-6 cell lLine